Drugs / Policosanol
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00312923 | Sep 2005 → Jul 2009 | HIV infectious disease, hyperlipidemia | Rush University Medical Center | Completed | No outcome recorded |
| Phase 32 trials · 1 missed | ||||||
| Phase 3 | NCT02543099 | Jun 2015 → Apr 2016 | — | General Hospital of Chinese Armed Police Forces | Unknown | No outcome recorded |
| Phase 3 | NCT00288483 | Sep 2000 → Jul 2001 | hyperlipoproteinemia | Drug Commission of the German Medical Association | Terminated | Missed primary |
| Phase 42 trials | ||||||
| Phase 4 | NCT01490229 | Jan 2013 → Dec 2014 | coronary artery disorder | University of Roma La Sapienza | Unknown | No outcome recorded |
| Phase 4 | NCT01371058 | Mar 2011 → Sep 2012 | coronary artery disorder | Shenyang Northern Hospital | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00255216 | Jan → Aug 2005 | hyperlipidemia | Wake Forest University Health Sciences | Completed | No outcome recorded |
| Comparator or background therapy4 trials | ||||||
| Phase 4 | NCT05365425 Comparator | Jun 2023 → Dec 2026 expected | atherosclerosis, hyperlipidemia, type 2 diabetes mellitus | Seoul National University Bundang Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT01649986 Comparator | Jan 2014 → Dec 2015 | hyperlipidemia | University of Roma La Sapienza | Unknown | No outcome recorded |
| Phase 4 | NCT02001883 Comparator | Nov 2013 → Dec 2014 | coronary artery disorder | University of Roma La Sapienza | Unknown | No outcome recorded |
| — | NCT00510809 Comparator | Jul 2007 → Mar 2010 | familial hypercholesterolemia | James Backes, PharmD | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | policosanol | “nutraceutical combined pill (1 capsule/day containing red yeast rice 200 mg, policosanol 10 mg, and berberine 500 mg).” NCT02001883 ↗9“os, 1 pill containing red yeast rice 200 mg, policosanol 10 mg, and berberine 500 mg, once daily, 1 year” NCT01490229 ↗ “1 capsule/day containing red yeast rice 200 mg, policosanol 10 mg, and berberine 500 mg” NCT01649986 ↗ |
| Modality | Small molecule | — CHEMBL3707352 ↗ |
| Route | Oral | “Policosanol supplement (oral capsule) vs. placebo” NCT00255216 ↗ |